Detailed Information on Publication Record
2023
Missorting of plasma miRNAs in aging and Alzheimer's disease
CARNA, Maria, Jan S. NOVOTNY, Neda DRAGISIC, Hanus SLAVIK, Kateřina SHEARDOVÁ et. al.Basic information
Original name
Missorting of plasma miRNAs in aging and Alzheimer's disease
Authors
CARNA, Maria, Jan S. NOVOTNY (203 Czech Republic), Neda DRAGISIC, Hanus SLAVIK (203 Czech Republic), Kateřina SHEARDOVÁ (203 Czech Republic, belonging to the institution), Yonas E. GEDA, Martin VYHNALEK (203 Czech Republic), Jan LACZO (203 Czech Republic), Jakub HORT (203 Czech Republic), Zixu MAO, Robert A. RISSMAN, Marian HAJDUCH (203 Czech Republic), Eric B. DAMMER and Gorazd B. STOKIN (guarantor)
Edition
Journal of Neurochemistry, Hoboken, Wiley-Blackwell, 2023, 0022-3042
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30210 Clinical neurology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.700 in 2022
RIV identification code
RIV/00216224:14110/23:00130750
Organization unit
Faculty of Medicine
UT WoS
000959282900001
Keywords in English
aging; Alzheimer's disease; endosomes; extracellular vesicles; miRNA; ncRNA; plasma; short sequence motifs
Tags
International impact, Reviewed
Změněno: 10/5/2023 14:06, Mgr. Tereza Miškechová
Abstract
V originále
The observation that aging is regulated by microRNAs (miRNA) and at the same time represents the greatest risk factor for Alzheimer's disease (AD), prompted us to examine the circulating miRNA network in AD beyond aging. We here show that plasma miRNAs in aging are downregulated and predicted to be preferentially targeted to the extracellular vesicle (EV) content. In AD, miRNAs are further downregulated, display altered proportions of motifs relevant to their loading into EVs and secretion propensity, and are forecast to be found exclusively in EVs. The circulating miRNA network in AD, therefore, reflects pathological exacerbation of the aging process whereby physiological suppression of AD pathology by miRNAs becomes insufficient.